MD1652F2 - Proteina cu activitate de tip citochina, ADN recombinant, codificator pentru aceasta proteina, celule si microorganisme transformate, vector de expresie, procedeu de obtinere a proteinei si remediu care contine aceasta proteina - Google Patents
Proteina cu activitate de tip citochina, ADN recombinant, codificator pentru aceasta proteina, celule si microorganisme transformate, vector de expresie, procedeu de obtinere a proteinei si remediu care contine aceasta proteina Download PDFInfo
- Publication number
- MD1652F2 MD1652F2 MD97-0099A MD970099A MD1652F2 MD 1652 F2 MD1652 F2 MD 1652F2 MD 970099 A MD970099 A MD 970099A MD 1652 F2 MD1652 F2 MD 1652F2
- Authority
- MD
- Moldova
- Prior art keywords
- leu
- protein
- ala
- lys
- asn
- Prior art date
Links
- 108090000623 proteins and genes Proteins 0.000 title abstract 5
- 102000004169 proteins and genes Human genes 0.000 title abstract 5
- 239000013604 expression vector Substances 0.000 title 1
- 244000005700 microbiome Species 0.000 title 1
- 150000001413 amino acids Chemical class 0.000 abstract 2
- CCDFBRZVTDDJNM-GUBZILKMSA-N Ala-Leu-Glu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O CCDFBRZVTDDJNM-GUBZILKMSA-N 0.000 abstract 1
- YSUVMPICYVWRBX-VEVYYDQMSA-N Arg-Asp-Thr Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O YSUVMPICYVWRBX-VEVYYDQMSA-N 0.000 abstract 1
- NKBQZKVMKJJDLX-SRVKXCTJSA-N Arg-Glu-Leu Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O NKBQZKVMKJJDLX-SRVKXCTJSA-N 0.000 abstract 1
- IBLAOXSULLECQZ-IUKAMOBKSA-N Asn-Ile-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](N)CC(N)=O IBLAOXSULLECQZ-IUKAMOBKSA-N 0.000 abstract 1
- FHETWELNCBMRMG-HJGDQZAQSA-N Asn-Leu-Thr Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O FHETWELNCBMRMG-HJGDQZAQSA-N 0.000 abstract 1
- CMYVIUWVYHOLRD-ZLUOBGJFSA-N Cys-Ser-Ala Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(O)=O CMYVIUWVYHOLRD-ZLUOBGJFSA-N 0.000 abstract 1
- TWHDOEYLXXQYOZ-FXQIFTODSA-N Gln-Asn-Gln Chemical compound C(CC(=O)N)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)O)N TWHDOEYLXXQYOZ-FXQIFTODSA-N 0.000 abstract 1
- PXXGVUVQWQGGIG-YUMQZZPRSA-N Glu-Gly-Arg Chemical compound OC(=O)CC[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CCCN=C(N)N PXXGVUVQWQGGIG-YUMQZZPRSA-N 0.000 abstract 1
- BMWFDYIYBAFROD-WPRPVWTQSA-N Gly-Pro-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)CN BMWFDYIYBAFROD-WPRPVWTQSA-N 0.000 abstract 1
- JBCLFWXMTIKCCB-UHFFFAOYSA-N H-Gly-Phe-OH Natural products NCC(=O)NC(C(O)=O)CC1=CC=CC=C1 JBCLFWXMTIKCCB-UHFFFAOYSA-N 0.000 abstract 1
- TVMNTHXFRSXZGR-IHRRRGAJSA-N His-Lys-Val Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(O)=O TVMNTHXFRSXZGR-IHRRRGAJSA-N 0.000 abstract 1
- PHIXPNQDGGILMP-YVNDNENWSA-N Ile-Glu-Glu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N PHIXPNQDGGILMP-YVNDNENWSA-N 0.000 abstract 1
- DFJJAVZIHDFOGQ-MNXVOIDGSA-N Ile-Glu-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O)N DFJJAVZIHDFOGQ-MNXVOIDGSA-N 0.000 abstract 1
- SENJXOPIZNYLHU-UHFFFAOYSA-N L-leucyl-L-arginine Natural products CC(C)CC(N)C(=O)NC(C(O)=O)CCCN=C(N)N SENJXOPIZNYLHU-UHFFFAOYSA-N 0.000 abstract 1
- DKEZVKFLETVJFY-CIUDSAMLSA-N Leu-Cys-Asn Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(=O)N)C(=O)O)N DKEZVKFLETVJFY-CIUDSAMLSA-N 0.000 abstract 1
- SGIIOQQGLUUMDQ-IHRRRGAJSA-N Leu-His-Val Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](C(C)C)C(=O)O)N SGIIOQQGLUUMDQ-IHRRRGAJSA-N 0.000 abstract 1
- USLNHQZCDQJBOV-ZPFDUUQYSA-N Leu-Ile-Asn Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(O)=O USLNHQZCDQJBOV-ZPFDUUQYSA-N 0.000 abstract 1
- KYIIALJHAOIAHF-KKUMJFAQSA-N Leu-Leu-His Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CC1=CN=CN1 KYIIALJHAOIAHF-KKUMJFAQSA-N 0.000 abstract 1
- KPYAOIVPJKPIOU-KKUMJFAQSA-N Leu-Lys-Lys Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(O)=O KPYAOIVPJKPIOU-KKUMJFAQSA-N 0.000 abstract 1
- GCXGCIYIHXSKAY-ULQDDVLXSA-N Leu-Phe-Arg Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O GCXGCIYIHXSKAY-ULQDDVLXSA-N 0.000 abstract 1
- RGUXWMDNCPMQFB-YUMQZZPRSA-N Leu-Ser-Gly Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CO)C(=O)NCC(O)=O RGUXWMDNCPMQFB-YUMQZZPRSA-N 0.000 abstract 1
- IXHKPDJKKCUKHS-GARJFASQSA-N Lys-Ala-Pro Chemical compound C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CCCCN)N IXHKPDJKKCUKHS-GARJFASQSA-N 0.000 abstract 1
- QBEPTBMRQALPEV-MNXVOIDGSA-N Lys-Ile-Glu Chemical compound OC(=O)CC[C@@H](C(O)=O)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](N)CCCCN QBEPTBMRQALPEV-MNXVOIDGSA-N 0.000 abstract 1
- YJNDFEWPGLNLNH-IHRRRGAJSA-N Met-Tyr-Cys Chemical compound CSCC[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CS)C(O)=O)CC1=CC=C(O)C=C1 YJNDFEWPGLNLNH-IHRRRGAJSA-N 0.000 abstract 1
- SITLTJHOQZFJGG-UHFFFAOYSA-N N-L-alpha-glutamyl-L-valine Natural products CC(C)C(C(O)=O)NC(=O)C(N)CCC(O)=O SITLTJHOQZFJGG-UHFFFAOYSA-N 0.000 abstract 1
- 101100342977 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) leu-1 gene Proteins 0.000 abstract 1
- VJEZWOSKRCLHRP-MELADBBJSA-N Phe-Cys-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CS)NC(=O)[C@H](CC2=CC=CC=C2)N)C(=O)O VJEZWOSKRCLHRP-MELADBBJSA-N 0.000 abstract 1
- FDMKYQQYJKYCLV-GUBZILKMSA-N Pro-Pro-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H]1NCCC1 FDMKYQQYJKYCLV-GUBZILKMSA-N 0.000 abstract 1
- BTKUIVBNGBFTTP-WHFBIAKZSA-N Ser-Ala-Gly Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C)C(=O)NCC(O)=O BTKUIVBNGBFTTP-WHFBIAKZSA-N 0.000 abstract 1
- BSNZTJXVDOINSR-JXUBOQSCSA-N Thr-Ala-Leu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(O)=O BSNZTJXVDOINSR-JXUBOQSCSA-N 0.000 abstract 1
- UMIACFRBELJMGT-GQGQLFGLSA-N Trp-Ser-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)N UMIACFRBELJMGT-GQGQLFGLSA-N 0.000 abstract 1
- IZFVRRYRMQFVGX-NRPADANISA-N Val-Ala-Gln Chemical compound C[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](C(C)C)N IZFVRRYRMQFVGX-NRPADANISA-N 0.000 abstract 1
- UGFMVXRXULGLNO-XPUUQOCRSA-N Val-Ser-Gly Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CO)C(=O)NCC(O)=O UGFMVXRXULGLNO-XPUUQOCRSA-N 0.000 abstract 1
- 235000001014 amino acid Nutrition 0.000 abstract 1
- 108010081551 glycylphenylalanine Proteins 0.000 abstract 1
- 108010025306 histidylleucine Proteins 0.000 abstract 1
- 108010000761 leucylarginine Proteins 0.000 abstract 1
- 239000002243 precursor Substances 0.000 abstract 1
- 235000018102 proteins Nutrition 0.000 abstract 1
- 108010015385 valyl-prolyl-proline Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
- C07K14/5446—IL-16
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
- C07K14/5437—IL-13
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/244—Interleukins [IL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F02—COMBUSTION ENGINES; HOT-GAS OR COMBUSTION-PRODUCT ENGINE PLANTS
- F02B—INTERNAL-COMBUSTION PISTON ENGINES; COMBUSTION ENGINES IN GENERAL
- F02B75/00—Other engines
- F02B75/02—Engines characterised by their cycles, e.g. six-stroke
- F02B2075/022—Engines characterised by their cycles, e.g. six-stroke having less than six strokes per cycle
- F02B2075/027—Engines characterised by their cycles, e.g. six-stroke having less than six strokes per cycle four
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9103904A FR2674537B1 (fr) | 1991-03-29 | 1991-03-29 | Proteine a activite de type cytokine, adn recombinant codant pour cette proteine, cellules animales transformees. |
| FR9200137A FR2685919B1 (fr) | 1992-01-08 | 1992-01-08 | Proteine a activite de type cytokine, adn recombinant codant pour cette proteine, cellules animales transformees. |
| PCT/FR1992/000280 WO1992017586A1 (fr) | 1991-03-29 | 1992-03-27 | Proteine a activite de type cytokine, adn recombinant codant pour cette proteine, cellules et micro-organismes transformes |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| MD970099A MD970099A (ro) | 1998-04-30 |
| MD1652F2 true MD1652F2 (ro) | 2001-04-30 |
| MD1652G2 MD1652G2 (ro) | 2001-12-31 |
Family
ID=26228598
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MD97-0099A MD1652G2 (ro) | 1991-03-29 | 1992-03-27 | Proteină cu activitate de tip citochină, ADN recombinant, codificator pentru această proteină, celule şi microorganisme transformate, vector de expresie, procedeu de obţinere a proteinei şi remediu care conţine această proteină |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US5652123A (ro) |
| EP (1) | EP0506574B1 (ro) |
| JP (1) | JP2865423B2 (ro) |
| AT (1) | ATE130869T1 (ro) |
| CA (1) | CA2083826C (ro) |
| DE (2) | DE69206301T2 (ro) |
| DK (1) | DK0506574T3 (ro) |
| ES (1) | ES2054601T3 (ro) |
| GR (2) | GR940300052T1 (ro) |
| HU (2) | HU217099B (ro) |
| IE (1) | IE72165B1 (ro) |
| MD (1) | MD1652G2 (ro) |
| WO (1) | WO1992017586A1 (ro) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5596072A (en) * | 1992-08-21 | 1997-01-21 | Schering Corporation | Method of refolding human IL-13 |
| EP0656947A1 (en) * | 1992-08-21 | 1995-06-14 | Schering Corporation | Human interleukin-13 |
| US6274711B1 (en) | 1993-06-14 | 2001-08-14 | Inserm, Institut National De La Sante Et De La Recherche Medicale | Purified mammalian CTLA-8 antigens and related reagents |
| DE69635608T2 (de) * | 1995-02-10 | 2006-10-26 | Novozymes A/S | Bacillus proteasen |
| CN1093174C (zh) * | 1995-02-10 | 2002-10-23 | 诺沃奇梅兹有限公司 | 芽孢杆菌属蛋白酶 |
| US6576232B1 (en) * | 1998-04-03 | 2003-06-10 | The Penn State Research Foundation | IL13 mutants |
| US7553487B2 (en) | 1998-12-14 | 2009-06-30 | Genetics Institute, Llc | Method and compositions for treating asthma |
| WO2000036103A1 (en) | 1998-12-14 | 2000-06-22 | Genetics Institute, Inc. | Cytokine receptor chain |
| AU2001253282A1 (en) | 2000-04-07 | 2001-10-23 | Heska Corporation | Compositions and methods related to canine igg and canine il-13 receptors |
| US20070104710A1 (en) * | 2002-06-28 | 2007-05-10 | Domants Limited | Ligand that has binding specificity for IL-4 and/or IL-13 |
| US20110223168A1 (en) * | 2002-12-27 | 2011-09-15 | Greg Winter | Ligand that has binding specificity for il-4 and/or il-13 |
| US20050059024A1 (en) * | 2003-07-25 | 2005-03-17 | Ambion, Inc. | Methods and compositions for isolating small RNA molecules |
| EP3718564B1 (en) | 2003-12-23 | 2023-10-11 | Genentech, Inc. | Novel anti-il 13 antibodies and uses thereof |
| US20090098142A1 (en) * | 2004-06-09 | 2009-04-16 | Kasaian Marion T | Methods and compositions for treating and monitoring treatment of IL-13-associated disorders |
| AR049390A1 (es) | 2004-06-09 | 2006-07-26 | Wyeth Corp | Anticuerpos contra la interleuquina-13 humana y usos de los mismos |
| US7501121B2 (en) | 2004-06-17 | 2009-03-10 | Wyeth | IL-13 binding agents |
| EP1824886B1 (en) | 2004-11-17 | 2010-12-22 | Amgen Inc. | Fully human monoclonal antibodies to il-13 |
| US20080044420A1 (en) * | 2005-05-11 | 2008-02-21 | Heavner George A | Anti-IL-13 antibodies, compositions, methods and uses |
| CA2623429C (en) * | 2005-09-30 | 2015-01-13 | Medimmune Limited | Interleukin-13 antibody composition |
| ES2902063T3 (es) | 2006-09-08 | 2022-03-24 | Abbvie Bahamas Ltd | Proteínas de unión a interleucina-13 |
| AR066240A1 (es) * | 2007-04-23 | 2009-08-05 | Wyeth Corp | Metodos y composiciones para tratar y monitorear el tratamiento de trastornos asociados con il-13 |
| NZ591098A (en) | 2008-08-20 | 2012-08-31 | Centocor Ortho Biotech Inc | Engineered anti-il-13 antibodies, compositions, methods and uses |
| GB0904214D0 (en) | 2009-03-11 | 2009-04-22 | Ucb Pharma Sa | Biological products |
| FR2957799B1 (fr) * | 2010-03-26 | 2012-08-17 | Inst Des Vaisseaux Et Du Sang | Compositions proangiogeniques, leur procede de preparation et leurs utilisations |
| CA3174012A1 (en) | 2013-09-13 | 2015-03-19 | Genentech, Inc. | Compositions and methods for detecting and quantifying host cell protein in cell lines and recombinant polypeptide products |
| IL244149B2 (en) | 2013-09-13 | 2025-09-01 | Genentech Inc | Methods and compositions containing purified recombinant polypeptides |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL92685A0 (en) * | 1988-12-16 | 1990-09-17 | Us Commerce | Dna encoding lymphokine/cytokine like proteins,cells transformed thereby and production of said proteins and antibodies against them |
-
1992
- 1992-03-27 JP JP4507703A patent/JP2865423B2/ja not_active Expired - Lifetime
- 1992-03-27 ES ES92400858T patent/ES2054601T3/es not_active Expired - Lifetime
- 1992-03-27 AT AT92400858T patent/ATE130869T1/de active
- 1992-03-27 EP EP92400858A patent/EP0506574B1/fr not_active Expired - Lifetime
- 1992-03-27 DK DK92400858.4T patent/DK0506574T3/da active
- 1992-03-27 DE DE69206301T patent/DE69206301T2/de not_active Expired - Lifetime
- 1992-03-27 HU HU9203753A patent/HU217099B/hu unknown
- 1992-03-27 CA CA002083826A patent/CA2083826C/en not_active Expired - Lifetime
- 1992-03-27 WO PCT/FR1992/000280 patent/WO1992017586A1/fr not_active Ceased
- 1992-03-27 DE DE0506574T patent/DE506574T1/de active Pending
- 1992-03-27 MD MD97-0099A patent/MD1652G2/ro unknown
- 1992-03-30 IE IE921016A patent/IE72165B1/en not_active IP Right Cessation
- 1992-11-27 HU HU9203753A patent/HU9203753D0/hu unknown
-
1994
- 1994-08-31 GR GR940300052T patent/GR940300052T1/el unknown
-
1995
- 1995-01-11 US US08/371,121 patent/US5652123A/en not_active Expired - Lifetime
-
1996
- 1996-02-21 GR GR960400446T patent/GR3019043T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US5652123A (en) | 1997-07-29 |
| MD1652G2 (ro) | 2001-12-31 |
| GR3019043T3 (en) | 1996-05-31 |
| ATE130869T1 (de) | 1995-12-15 |
| DK0506574T3 (da) | 1996-04-09 |
| DE69206301T2 (de) | 1996-06-13 |
| ES2054601T3 (es) | 1996-04-01 |
| HU9203753D0 (en) | 1993-03-29 |
| ES2054601T1 (es) | 1994-08-16 |
| IE72165B1 (en) | 1997-03-26 |
| HK1007435A1 (en) | 1999-04-09 |
| HUT68162A (en) | 1995-05-29 |
| CA2083826C (en) | 1999-04-27 |
| JP2865423B2 (ja) | 1999-03-08 |
| WO1992017586A1 (fr) | 1992-10-15 |
| CA2083826A1 (en) | 1992-09-30 |
| DE69206301D1 (de) | 1996-01-11 |
| MD970099A (ro) | 1998-04-30 |
| GR940300052T1 (en) | 1994-08-31 |
| JPH06500567A (ja) | 1994-01-20 |
| HU217099B (hu) | 1999-11-29 |
| EP0506574B1 (fr) | 1995-11-29 |
| DE506574T1 (de) | 1994-11-17 |
| IE921016A1 (en) | 1992-10-07 |
| EP0506574A1 (fr) | 1992-09-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MD1652F2 (ro) | Proteina cu activitate de tip citochina, ADN recombinant, codificator pentru aceasta proteina, celule si microorganisme transformate, vector de expresie, procedeu de obtinere a proteinei si remediu care contine aceasta proteina | |
| CA2050300A1 (en) | Tnf-inhibiting proteins and the preparation thereof | |
| GR3026553T3 (en) | Porcine CNP gene and precursor protein | |
| HU9401989D0 (en) | A novel human kunitz-type protease inhibitor and variants thereof | |
| EP1531791A4 (en) | PREVENTION AND REDUCTION OF BLOOD LOSS | |
| AU1633200A (en) | Human parathyroid hormone modifications, preparation and use | |
| RU94036773A (ru) | Домен i ингибитора протеазы, днк, вектор, клетка, способ получения ингибитора протеазы, фармацевтическая композиция, применение домена i | |
| CA2002924A1 (en) | Anti-Thrombins | |
| DE69201438D1 (en) | Als therapeutika geeignete peptide. | |
| CA2083837A1 (en) | Recombinant dna coding for a novel protein having .beta.-1,3 glucanase activity, bacteria containing this dna, transformed plant cells and plants | |
| NZ334714A (en) | Liver proteins as agents against autoimmune diseases | |
| CA2077590A1 (en) | Recombinant dna coding for a protein with endochitinase activity | |
| EP0292257A3 (en) | Peptides having anf activity | |
| AU8302791A (en) | Recombinant gene coding for a protein having an endochitinase activity | |
| AU585167B2 (en) | Novel substrate peptides | |
| IL74703A (en) | Process for the preparation of peptides and some tripeptides as intermediates therefor | |
| EP0687685A4 (en) | PHYSIOLOGICALLY ACTIVE PEPTIDES | |
| EP1908781A3 (en) | Modulation of immune response and methods based thereon | |
| WO1997012036A3 (en) | Bone stimulating factor | |
| IL115825A0 (en) | Therapeutic protein | |
| PT100299A (pt) | Analogo de hirudina, metodo para a sua producao e anti-coagulante contendo-o, e vector de secrecao , microorganismos transformados com o referido vector e metodo para a producao de produtos a partir dos referidos microorganismos | |
| CA2311684A1 (en) | Chemically-modified g-csf |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PD99 | Pending application | ||
| MK4A | Patent for invention expired |